HRP20050815A2 - 2-(butyl-1-sulfonylamino)-n-[1(r)-(6-methoxy-pyridin-3-yl)-propyl]-benzamid, the use thereof in the form of drug an pharmaceutical preparations containing said compound - Google Patents
2-(butyl-1-sulfonylamino)-n-[1(r)-(6-methoxy-pyridin-3-yl)-propyl]-benzamid, the use thereof in the form of drug an pharmaceutical preparations containing said compoundInfo
- Publication number
- HRP20050815A2 HRP20050815A2 HR20050815A HRP20050815A HRP20050815A2 HR P20050815 A2 HRP20050815 A2 HR P20050815A2 HR 20050815 A HR20050815 A HR 20050815A HR P20050815 A HRP20050815 A HR P20050815A HR P20050815 A2 HRP20050815 A2 HR P20050815A2
- Authority
- HR
- Croatia
- Prior art keywords
- sulfonylamino
- pyridin
- methoxy
- propyl
- butyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/64—One oxygen atom attached in position 2 or 6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10312073A DE10312073A1 (de) | 2003-03-18 | 2003-03-18 | 2-(Butyl-1-sulfonylamino)-N-[1(R)-(6-methoxy-pyridin-3yl)-propyl]-benzamid, dessen Verwendung als Medikament sowie dieses enthaltende pharmazeutische Zubereitungen |
| PCT/EP2004/002247 WO2004083157A1 (de) | 2003-03-18 | 2004-03-05 | 2-(butyl-1-sulfonylamino)-n-[1(r)-(6-methoxy-pyridin-3-yl)-propyl]-benzamid, dessen verwendung als medikament sowie dieses enthaltende pharmazeutische zubereitungen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20050815A2 true HRP20050815A2 (en) | 2006-09-30 |
Family
ID=32920928
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HR20050815A HRP20050815A2 (en) | 2003-03-18 | 2005-09-16 | 2-(butyl-1-sulfonylamino)-n-[1(r)-(6-methoxy-pyridin-3-yl)-propyl]-benzamid, the use thereof in the form of drug an pharmaceutical preparations containing said compound |
Country Status (22)
| Country | Link |
|---|---|
| EP (1) | EP1606237A1 (de) |
| JP (1) | JP2006520343A (de) |
| KR (1) | KR20050110681A (de) |
| CN (1) | CN100361943C (de) |
| AR (1) | AR043622A1 (de) |
| AU (1) | AU2004222137A1 (de) |
| BR (1) | BRPI0408441A (de) |
| CA (1) | CA2519022A1 (de) |
| DE (1) | DE10312073A1 (de) |
| HK (1) | HK1086819A1 (de) |
| HR (1) | HRP20050815A2 (de) |
| MA (1) | MA27749A1 (de) |
| MX (1) | MXPA05009763A (de) |
| MY (1) | MY176510A (de) |
| NO (1) | NO20054472L (de) |
| NZ (1) | NZ542476A (de) |
| PE (1) | PE20050307A1 (de) |
| RS (1) | RS20050690A (de) |
| RU (1) | RU2333202C2 (de) |
| TW (1) | TW200500342A (de) |
| WO (1) | WO2004083157A1 (de) |
| ZA (1) | ZA200506328B (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102004009931A1 (de) * | 2004-02-26 | 2005-09-15 | Aventis Pharma Deutschland Gmbh | Kv1.5-Blocker zur selektiven Steigerung der Vorhofkontraktilität und Behandlung der Herzinsuffizienz |
| US7569589B2 (en) | 2004-07-29 | 2009-08-04 | Merck & Co., Inc. | Potassium channel inhibitors |
| DE102005028845A1 (de) * | 2005-06-22 | 2006-12-28 | Sanofi-Aventis Deutschland Gmbh | Substituierte Heterocyclen, ihre Verwendung als Medikament sowie enthaltende pharmazeutische Zubereitungen |
| JP4943429B2 (ja) * | 2005-07-22 | 2012-05-30 | メルク・シャープ・エンド・ドーム・コーポレイション | カリウムチャネル阻害剤 |
| US9101616B2 (en) | 2009-05-29 | 2015-08-11 | Raqualia Pharma Inc. | Aryl substituted carboxamide derivatives as calcium or sodium channel blockers |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10121003A1 (de) * | 2001-04-28 | 2002-12-19 | Aventis Pharma Gmbh | Anthranilsäureamide, Verfahren zur Herstellung, ihrer Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen |
-
2003
- 2003-03-18 DE DE10312073A patent/DE10312073A1/de not_active Withdrawn
-
2004
- 2004-03-05 EP EP04717628A patent/EP1606237A1/de not_active Withdrawn
- 2004-03-05 RS YUP-2005/0690A patent/RS20050690A/sr unknown
- 2004-03-05 PE PE2004000245A patent/PE20050307A1/es not_active Application Discontinuation
- 2004-03-05 KR KR1020057017498A patent/KR20050110681A/ko not_active Application Discontinuation
- 2004-03-05 BR BRPI0408441-1A patent/BRPI0408441A/pt not_active IP Right Cessation
- 2004-03-05 RU RU2005132163/04A patent/RU2333202C2/ru not_active IP Right Cessation
- 2004-03-05 WO PCT/EP2004/002247 patent/WO2004083157A1/de active Application Filing
- 2004-03-05 JP JP2006504553A patent/JP2006520343A/ja not_active Abandoned
- 2004-03-05 NZ NZ542476A patent/NZ542476A/en unknown
- 2004-03-05 CN CNB2004800060168A patent/CN100361943C/zh not_active Expired - Fee Related
- 2004-03-05 CA CA002519022A patent/CA2519022A1/en not_active Abandoned
- 2004-03-05 MX MXPA05009763A patent/MXPA05009763A/es active IP Right Grant
- 2004-03-05 AU AU2004222137A patent/AU2004222137A1/en not_active Abandoned
- 2004-03-16 TW TW093106899A patent/TW200500342A/zh unknown
- 2004-03-16 AR ARP040100866A patent/AR043622A1/es unknown
- 2004-03-17 MY MYPI20040938A patent/MY176510A/en unknown
-
2005
- 2005-08-08 ZA ZA200506328A patent/ZA200506328B/en unknown
- 2005-09-16 HR HR20050815A patent/HRP20050815A2/xx not_active Application Discontinuation
- 2005-09-19 MA MA28502A patent/MA27749A1/fr unknown
- 2005-09-27 NO NO20054472A patent/NO20054472L/no not_active Application Discontinuation
-
2006
- 2006-06-16 HK HK06106891A patent/HK1086819A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200506328B (en) | 2006-04-26 |
| AU2004222137A1 (en) | 2004-09-30 |
| NO20054472L (no) | 2005-09-27 |
| CA2519022A1 (en) | 2004-09-30 |
| AR043622A1 (es) | 2005-08-03 |
| PE20050307A1 (es) | 2005-06-08 |
| RU2005132163A (ru) | 2006-04-10 |
| MY176510A (en) | 2020-08-12 |
| RS20050690A (sr) | 2008-04-04 |
| CN100361943C (zh) | 2008-01-16 |
| DE10312073A1 (de) | 2004-09-30 |
| MXPA05009763A (es) | 2006-01-27 |
| BRPI0408441A (pt) | 2006-04-04 |
| CN1756728A (zh) | 2006-04-05 |
| KR20050110681A (ko) | 2005-11-23 |
| MA27749A1 (fr) | 2006-02-01 |
| TW200500342A (en) | 2005-01-01 |
| HK1086819A1 (en) | 2006-09-29 |
| EP1606237A1 (de) | 2005-12-21 |
| WO2004083157A1 (de) | 2004-09-30 |
| JP2006520343A (ja) | 2006-09-07 |
| NZ542476A (en) | 2008-05-30 |
| RU2333202C2 (ru) | 2008-09-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR031430A1 (es) | Compuestos de bisarilo orto, meta-sustituidos, procedimientos para su preparacion, su utilizacion como medicamento como tambien los preparados farmaceuticos que los contienen | |
| HRP20050663A2 (en) | Malonamide derivatives as gamma-secretase inhibitors | |
| BR0213242A (pt) | Composto ou um seu sal ou solvato, composto e seus sais de adição de ácido fisiologicamente aceitáveis, composição farmacêutica, método de tratamento de um ou mais distúrbios, uso de um composto, e, processo de preparação de um composto | |
| RS82003A (en) | Anthranilic acid amides, method for the production thereof, their use as antiarhythmia agents, and pharmaceutical preparations thereof | |
| RS50140B (sr) | Postupak za dobijanje perkihinina i njegova upotreba | |
| BR0312464A (pt) | Inibidores de tirosina quinases | |
| BR0215777A (pt) | Composto, método para preparar o mesmo, composição farmacêutica para prevenir e tratar cardioisquemia, cerebroisquemia, oclusão arterial cerebral e para melhorar microcirculação do cérebro, e uso do composto | |
| WO2002085909A8 (en) | 9-deazaguanine derivatives as inhibitors of gsk-3 | |
| ATE307810T1 (de) | Imidazol-2-carbonsäureamid derivate als raf- kinase-inhibitoren | |
| BR0210028A (pt) | Agentes antibacterianos | |
| MEP60908A (en) | 2'-substituted 1,1'-biphenyl-2-carbonamides, method for the production thereof, use thereof as a medicament and pharmaceutical preparations containing said compounds | |
| BRPI0408727A (pt) | composto, processo para preparar o mesmo, composição farmacêutica, método para tratar de uma condição ou estado de doença mediados pela atividade da quinase p38 ou mediados pelas citocinas produzidas pela atividade da quinase p38, e, uso de um composto | |
| ATE300541T1 (de) | Pyrazolopyridinderivate | |
| RU95111308A (ru) | Производные 2-амино-4-фенил-4-оксомасляной кислоты, способы получения, фармацевтическая композиция | |
| HRP20050815A2 (en) | 2-(butyl-1-sulfonylamino)-n-[1(r)-(6-methoxy-pyridin-3-yl)-propyl]-benzamid, the use thereof in the form of drug an pharmaceutical preparations containing said compound | |
| SE9903894D0 (sv) | Novel compounds | |
| HK1120794A1 (en) | Substituted heterocycles, their use as medicament, and pharmaceutical preparations comprising them | |
| BR0115883A (pt) | Derivados de ácido amino-furan-2-il-acético e ácido amino-tien-2-il-acético substituìdos e seu emprego para o tratamento de cefaléia ou dor | |
| ATE253359T1 (de) | Antithrombotische mittel | |
| BR0318659A (pt) | derivados de prolina usados como ingredientes farmacêuticos ativos no tratamento de tumores | |
| DE69828522D1 (de) | Antithrombotische mittel | |
| DE69103773D1 (de) | Derivate von hydroxaminsäure die lipoxygenase hemmen. | |
| ATE299027T1 (de) | Verwendung von übersulfatierten polysacchariden als hiv-hemmer | |
| UY27372A1 (es) | Derivados de bencimidazol 1-aril-2-n, s u o-sustituidos, su uso para la obtención de medicamentos y preparados farmacéuticos que contienen estos derivados | |
| DE69910787D1 (de) | Neuartige, pharmazeutisch aktive verbindung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A1OB | Publication of a patent application | ||
| ARAI | Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application | ||
| ODRP | Renewal fee for the maintenance of a patent |
Payment date: 20090304 Year of fee payment: 6 |
|
| OBST | Application withdrawn |